Xenon Pharmaceuticals: Q4 Earnings Snapshot

SelfRugger · 2026-04-10T00:30:05+00:00

Xenon Pharmaceuticals reported a Q4 loss of $105.3 million, exceeding analysts' expectations for a lesser loss. For the year, total losses reached $345.9 million on revenue of $7.5 million.

SelfRugger

2026-04-10 00:30:05

Abstract generation in progress

Xenon Pharmaceuticals: Q4 Earnings Snapshot

Associated Press Finance

Fri, February 27, 2026 at 7:04 AM GMT+9 1 min read

In this article:

XENE

+0.77%

BURNABY, British Columbia (AP) — BURNABY, British Columbia (AP) — Xenon Pharmaceuticals Inc. (XENE) on Thursday reported a loss of $105.3 million in its fourth quarter.

The Burnaby, British Columbia-based company said it had a loss of $1.31 per share.

The results did not meet Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.20 per share.

For the year, the company reported a loss of $345.9 million, or $4.36 per share. Revenue was reported as $7.5 million.

This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on XENE at

Terms and Privacy Policy

Privacy Dashboard

More Info

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes